Isomorphic Labs Secures $2.1 Billion to Advance AI-Driven Drug Discovery
Isomorphic Labs, the London-based AI drug discovery company spun out of Google DeepMind in 2021, has successfully closed a US$2.1 billion funding round. The investment was led by Thrive Capital, with participation from i...